Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain.
Nat Struct Mol Biol. 2012 Jun 3;19(7):664-70. doi: 10.1038/nsmb.2315.
Epigenetic deregulation at a number of genomic loci is one of the hallmarks of cancer. A role for some RNA molecules in guiding repressive polycomb complex PRC2 to specific chromatin regions has been proposed. Here we use an in vivo cross-linking method to detect and identify direct PRC2-RNA interactions in human cancer cells, revealing a number of intronic RNA sequences capable of binding to the core component EZH2 and regulating the transcriptional output of its genomic counterpart. Overexpression of EZH2-bound intronic RNA for the H3K4 methyltransferase gene SMYD3 is concomitant with an increase in EZH2 occupancy throughout the corresponding genomic fragment and is sufficient to reduce levels of the endogenous transcript and protein, resulting in reduced growth capability in cell culture and animal models. These findings reveal the role of intronic RNAs in fine-tuning gene expression regulation at the level of transcriptional control.
基因组多个位置的表观遗传失调是癌症的特征之一。一些 RNA 分子在指导抑制性多梳复合物 PRC2 到特定染色质区域的作用已被提出。在这里,我们使用一种体内交联方法来检测和鉴定人癌细胞中直接的 PRC2-RNA 相互作用,揭示了许多能够结合核心成分 EZH2 并调节其基因组对应物转录输出的内含子 RNA 序列。H3K4 甲基转移酶基因 SMYD3 的 EZH2 结合内含子 RNA 的过表达伴随着整个相应基因组片段中 EZH2 占有率的增加,并且足以降低内源性转录本和蛋白质的水平,从而导致细胞培养和动物模型中的生长能力降低。这些发现揭示了内含子 RNA 在精细调节转录控制水平的基因表达调控中的作用。